European Journal of Molecular & Clinical Medicine

Abstract

Background: Heart failure is one of the leading causes of morbidity and mortality in the populations across the globe, as it is a common end point of many diseases viz. coronary artery diseases, cardiomyopathies, hypertension and many others enumerated in the forthcoming sections. So methodical management of this ailment will play a vital role in preventing unnecessary mortality and morbidity.
Methods: Patients admitted in cardiology ward, All India Institute of medical sciences New Delhi, Study period Between September 2019 To June 2022  with reduced left ventricular ejection fraction on 2D echocardiography, were selected as cases. Forty patients diagnosed with congestive cardiac failure were selected as the cases. 40 subjects with normal 2D echocardiography with normal renal function tests, normal Hb%, normal BMI were selected as controls.
Conclusion: This study emphasizes the role of NT pro BNP in the diagnosis of congestive heart failure. The level of NT proBNP rises exponentially with the onset of heart failure in contrast to BNP. So this creates a gross difference in blood values of NT proBNP in patients with congestive heart failure as compared to those without congestive failure.